H. Arai
发表
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors.
T. Naoe,
S. Akinaga,
Y. Shiotsu,
2008,
Bioorganic & medicinal chemistry letters.
M. Kasai,
H. Arai,
1994
.
M. Kasai,
H. Arai,
1993
.
H. Nishikawa,
M. Kasai,
H. Arai,
1995
.
J. J. Kim,
H. Kim,
Sang Hyup Lee,
2012,
Archives of pharmacal research.
H. Kim,
Sang Hyup Lee,
H. Arai,
2012,
Archives of Pharmacal Research.
T. Ashizawa,
K. Gomi,
M. Morimoto,
1994,
Journal of medicinal chemistry.
K. Tamao,
R. Sumiya,
H. Arai,
1986,
Journal of the American Chemical Society.
K. Tamao,
R. Sumiya,
H. Arai,
1986
.
K. Tamao,
Y. Nakagawa,
H. Arai,
1988
.
Y. Masuda,
H. Nishikawa,
M. Kasai,
1996
.
T. Tsuruo,
T. Ashizawa,
K. Gomi,
1991
.
S. Rockwell,
A. Sartorelli,
M. Tomasz,
1993,
Cancer research.
I. Fujii,
N. Hirayama,
M. Kasai,
1997
.
S. Rockwell,
A. Sartorelli,
M. Tomasz,
1998,
Oncology research.
M. Kasai,
H. Arai,
1991
.
D. Ross,
D. Siegel,
N. Gibson,
1992,
Biochemistry.
I. Fujii,
N. Hirayama,
M. Kasai,
1997
.
M. Kasai,
H. Arai,
1995
.
T. Ashizawa,
K. Gomi,
M. Morimoto,
1994,
The Journal of antibiotics.
T. Tsuruo,
K. Gomi,
M. Okabe,
2004,
Cancer Chemotherapy and Pharmacology.
H. Nakano,
H. Saito,
M. Kasai,
1993,
Cancer research.
M. Kasai,
H. Arai,
1995
.
T. Naoe,
M. Shimizu,
S. Akinaga,
2007,
Clinical Cancer Research.
D. Ross,
D. Siegel,
N. Gibson,
1993,
Molecular pharmacology.
S. Arai,
T. Yamagishi,
M. Hida,
1991
.
S. Arai,
T. Yamagishi,
M. Hida,
1992
.
S. Arai,
T. Yamagishi,
M. Hida,
1992
.
S. Arai,
T. Yamagishi,
M. Hida,
1992
.
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors.
T. Naoe,
S. Akinaga,
Y. Shiotsu,
2008,
Bioorganic & medicinal chemistry letters.